Top-notch biotech stock Dyne Therapeutics broke out Monday after the company unveiled promising test results for a pair of muscular dystrophy treatments. Please watch the video at Investors.com ...

Dyne Testing, an Intertronics brand, presents the Sigma 702 Force Tensiometer from Biolin Scientific, a standalone instrument for precise surface tension and interfacial tension measurement. The Sigma ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Dyne Therapeutics Inc (Symbol: DYN) entered into oversold territory, hitting an RSI reading ...

Dyne Therapeutics (DYN) announced new long-term clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 demonstrating unprecedented and sustained functional improvement at the selected ...

Use of DYNE-101 is leading to improvements in muscle, and specifically finger, function in myotonic dystrophy type 1 patients ...